Please provide your email address to receive an email when new articles are posted on . The next new treatment for rheumatoid arthritis could come from the unlikeliest of sources. Researchers based at ...
Please provide your email address to receive an email when new articles are posted on . Methotrexate use at the pre-arthritis stage of symptoms and subclinical inflammation fails to prevent clinical ...
Ra Pharmaceuticals Presents Pre-Clinical Data for Zilucoplan XR at the 6 th Annual Peptides Congress
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today presented pre-clinical data for an extended release (XR) formulation of zilucoplan at the 6 th Annual Peptides Congress, ...
A new therapeutic approach for rheumatoid arthritis (RA) could help prolong the time between flare-ups and even prevent the onset of the disease in at-risk patients. This is the promise of a new study ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Rheumatoid arthritis (RA) is currently diagnosed and treated ...
Studies designed to shed light on the prediction of rheumatoid arthritis (RA) are showing substantial promise -- not only for RA but a host of other rheumatic diseases. Rheumatology care professionals ...
As a chronic condition, rheumatoid arthritis (RA) can't be cured, so treatment focuses on managing the disease and controlling its progression. Although current treatments help control RA symptoms in ...
Everybody's different when it comes to rheumatoid arthritis (RA). Your symptoms may not be the same as those of a friend or neighbor who has the same disease. How your condition changes over time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results